PT Kimia Farma Tbk (IDX:KAEF)

Market Cap	3.53T +30.7%
Revenue (ttm)	9.09T -5.1%
Net Income	-158.33B
EPS	-28.44
Shares Out	5.57B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,028,100
Average Volume	3,937,400
Open	530.00
Previous Close	510.00
Day's Range	530.00 - 635.00
52-Week Range	444.00 - 765.00
Beta	1.10
RSI	80.11
Earnings Date	Jun 2, 2026

About PT Kimia Farma Tbk

PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Other segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrups, injections, ointments, creams, suppositories, semisolid dosage forms, and health supplements; traditional medicines; generic drugs, such as paracetam...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1817
• Employees: 9,838
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KAEF

Financial Performance

In 2025, PT Kimia Farma Tbk's revenue was 9.22 trillion, a decrease of -7.20% compared to the previous year's 9.94 trillion. Losses were -334.96 billion, -60.23% less than in 2024.